Old Web
English
Sign In
Acemap
>
Paper
>
EP1.01-28 Real World Use of Afatinib in NSCLC EGFRm+ Patients Outside Clinical Trials: A FAETT Experience
EP1.01-28 Real World Use of Afatinib in NSCLC EGFRm+ Patients Outside Clinical Trials: A FAETT Experience
2019
I Ramos García
Aniceto Méndez Sánchez
Angel Ortega
J Pradera
Manuel Cobo
Miguel Ángel Moreno
Isidoro Barneto
Sofia Ruiz
Isolda Fernandez
T. Garcia
F. Toscano
J. M. Trigo Perez
Keywords:
Oncology
Afatinib
Clinical trial
General surgery
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]